Last reviewed · How we verify
NCT03927430
Surgical Outcome of Macular Membrane Peeling Associated With Significant Macular Drusen
trial testing pars plana vitrectomy with membrane peeling in Epiretinal Membrane in 40 participants. Completed in 1 March 2019.
1 March 2019
Quick facts
| Lead sponsor | Klinikum Chemnitz gGmbH |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 1 January 2019 |
| Primary completion | 1 March 2019 |
| Estimated completion | 1 March 2019 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- pars plana vitrectomy with membrane peeling
Conditions studied
- Epiretinal Membrane — all drugs for Epiretinal Membrane →
- Macular Holes — all drugs for Macular Holes →
- Age Related Macular Degeneration — all drugs for Age Related Macular Degeneration →
Sponsor
Klinikum Chemnitz gGmbH
Who can join
18 and older, any sex, with Epiretinal Membrane or Macular Holes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Surgical outcome of patients with macular drusen and co-existing abnormalities of the vitreoretinal interface, who routinely undergo pars plana vitrectomy with membrane peeling, is evaluated. Best corrected visual acuity as well as optical coherence tomography data are compared at baseline and last follow up. The rate of development of choroidal neovascularization postoperatively is noted.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
To Peel or Not to Peel: Pars Plana Vitrectomy with Macular Membrane Peel in Eyes with Abnormalities of Vitreomacular Interface and Coexisting Dry Age-Related Macular Degeneration.
Furashova O, Engelmann K. · · 2020 · cited 5× · PMID 32103885 · DOI 10.2147/opth.s240480
Verify or expand the search:
- PubMed search for NCT03927430
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Epiretinal Membrane
Currently open trials in the same condition.
- NCT07019896 — Minimal Vitrectomy Surgery for Epiretinal Membrane · NA · recruiting
- NCT06719739 — Functional IOL Implantation in Patients With Epiretinal Membrane · NA · recruiting
- NCT06948851 — New Postoperative Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling Due to Epiretinal Membranes · active not recruiting
- NCT05145491 — Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM · NA · recruiting
- NCT04306718 — Cultivation of Hyalocytes From ILM and ERM Samples: a Pilot Study · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03927430 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Klinikum Chemnitz gGmbH
- Last refreshed: 1 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03927430.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing